Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA requirement after TIVA with propofol + remifentanil vs propofol + dexmedetomidine in PLIF surgery
KCT0001041Phase 4Completed
- Sponsor
- Seoul St. Mary's Hospital
- Start
- Sep 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of propofol, remifentanil and dexmedetomidine in postoperative pain (2 arms), sponsored by Seoul St. Mary's Hospital. Primary endpoint: Postoperative PCA requirement. Started Sep 2013; status: completed.
02
Drugs
propofolremifentanildexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0001041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001041.